UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis

Cardiovascular diabetology, 2021-06, Vol.20 (1), p.130-130, Article 130

2021

Volltextzugriff (PDF)

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19

Diabetes research and clinical practice, 2020-06, Vol.164, p.108217-108217, Article 108217

2020

Volltextzugriff (PDF)

Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort Study

Hypertension (Dallas, Tex. 1979), 2021-03, Vol.77 (3), p.846-855

2021

Volltextzugriff (PDF)

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19

Diabetes research and clinical practice, 2020-06, Vol.164, p.108217-108217

2020

Volltextzugriff (PDF)

Sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real‐world clinical practice? A systematic review and meta‐analysis of observational studies

Diabetes, obesity & metabolism, 2023-02, Vol.25 (2), p.501-515

2023

Volltextzugriff (PDF)

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

Diabetes care, 1998-04, Vol.21 (4), p.641-648

1998

Volltextzugriff (PDF)

Sodium‐glucose cotransporter‐2 inhibitors and kidney outcomes in real‐world type 2 diabetes populations: A systematic review and meta‐analysis of observational studies

Diabetes, obesity & metabolism, 2023-08, Vol.25 (8), p.2310-2330

2023

Volltextzugriff (PDF)

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study

European heart journal, 2008-09, Vol.29 (18), p.2244-2251

2008

Volltextzugriff (PDF)

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism

Diabetic medicine, 2021-05, Vol.38 (5), p.e14452-n/a

2021

Volltextzugriff (PDF)

A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population

Nephrology, dialysis, transplantation, 2024-03

2024

Volltextzugriff (PDF)

Hypoglycemia, diabetes therapies and driving categories in type 2 diabetes

Current medical research and opinion, 2016-06, Vol.32 (6), p.1005-1012

2016

Volltextzugriff (PDF)

Adult Refsum Disease: A Form of Tapetoretinal Dystrophy Accessible to Therapy

Survey of ophthalmology, 2010-11, Vol.55 (6), p.531-538

2010

Volltextzugriff (PDF)

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

The lancet. Diabetes & endocrinology, 2018-04, Vol.6 (4), p.310-318

2018

Volltextzugriff (PDF)

Novel diabetes subgroups

The lancet. Diabetes & endocrinology, 2018-06, Vol.6 (6), p.439-439

2018

Volltextzugriff (PDF)

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol

Diabetes therapy, 2019-06, Vol.10 (3), p.1163-1170

2019

Volltextzugriff (PDF)

Dashboards to reduce inappropriate prescribing of metformin and aspirin: A quality assurance programme in a primary care sentinel network

Primary care diabetes, 2021-12, Vol.15 (6), p.1075-1079

2021

Volltextzugriff (PDF)

The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease

Journal of neurology, neurosurgery and psychiatry, 2010-09, Vol.81 (9), p.954-957

2010

Volltextzugriff (PDF)

Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study

EClinicalMedicine, 2024-02, Vol.68, p.102426-102426, Article 102426

2024

Volltextzugriff (PDF)

All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK

Diabetes therapy, 2021-05, Vol.12 (5), p.1299-1311

2021

Volltextzugriff (PDF)

Nitric oxide and phosphodiesterase-5 inhibitors: possible treatments for COVID-19 in diabetes

British Journal of Diabetes, 2020-12, Vol.20 (2), p.81-83

2020

Volltextzugriff (PDF)

Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease

Journal of lipid research, 2003-08, Vol.44 (8), p.1481-1488

2003

Volltextzugriff (PDF)

Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes

BMJ open diabetes research & care, 2016, Vol.4 (1), p.e000192-e000192

2016

Volltextzugriff (PDF)

Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency

Molecular genetics and metabolism, 2012-11, Vol.107 (3), p.534-541

2012

Volltextzugriff (PDF)

Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation

Journal of neurochemistry, 2002-03, Vol.80 (5), p.727-735

2002

Volltextzugriff (PDF)

Injection related anxiety in insulin-treated diabetes

Diabetes research and clinical practice, 1999-12, Vol.46 (3), p.239-246

1999

Volltextzugriff (PDF)

1 – 25 von 116

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(102)

Publikationsform

Artikel
(115)
Buchkapitel
(1)

Sprache

Englisch
(116)

Erscheinungsjahr

n.n

Thema

Science & Technology
(69)
Life Sciences & Biomedicine
(62)
Humans
(41)
Endocrinology & Metabolism
(25)
Male
(22)
Diabetes
(19)
Female
(18)
Middle Aged
(17)
Adult
(16)
Type 2 Diabetes
(16)
Aged
(15)
Risk Factors
(14)
Biological And Medical Sciences
(12)
Medical Sciences
(12)
Cardiovascular System & Cardiology
(10)
Diabetes Mellitus, Type 2 - Drug Therapy
(10)
General & Internal Medicine
(10)
Diabetes Mellitus
(9)
Medicine, General & Internal
(9)
Animals
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Prescribing sodium-glucose co-transporter-2 inhibitors for type 2 diabetes in primary care: influence of renal function and heart failure diagnosis

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19

Association Between Blood Pressure Control and Coronavirus Disease 2019 Outcomes in 45 418 Symptomatic Patients With Hypertension: An Observational Cohort Study

The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19

Sodium‐glucose co‐transporter‐2 inhibitors in type 2 diabetes: Are clinical trial benefits for heart failure reflected in real‐world clinical practice? A systematic review and meta‐analysis of observational studies

Cardiovascular outcomes in type 2 diabetes. A double-blind placebo-controlled study of bezafibrate: the St. Mary's, Ealing, Northwick Park Diabetes Cardiovascular Disease Prevention (SENDCAP) Study

Sodium‐glucose cotransporter‐2 inhibitors and kidney outcomes in real‐world type 2 diabetes populations: A systematic review and meta‐analysis of observational studies

Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism

A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population

Hypoglycemia, diabetes therapies and driving categories in type 2 diabetes

Adult Refsum Disease: A Form of Tapetoretinal Dystrophy Accessible to Therapy

Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study

Novel diabetes subgroups

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol

Dashboards to reduce inappropriate prescribing of metformin and aspirin: A quality assurance programme in a primary care sentinel network

The effectiveness of long-term dietary therapy in the treatment of adult Refsum disease

Implementation of chronic kidney disease guidelines for sodium-glucose co-transporter-2 inhibitor use in primary care in the UK: a cross-sectional study

All-Cause and Cardiovascular Mortality Among Insulin-Naïve People With Type 2 Diabetes Treated With Insulin Detemir or Glargine: A Cohort Study in the UK

Nitric oxide and phosphodiesterase-5 inhibitors: possible treatments for COVID-19 in diabetes

Metabolism of phytanic acid and 3-methyl-adipic acid excretion in patients with adult Refsum disease

Patients' with type 2 diabetes willingness to pay for insulin therapy and clinical outcomes

Novel mutations of ABCA1 transporter in patients with Tangier disease and familial HDL deficiency

Refsum's disease: a peroxisomal disorder affecting phytanic acid α‐oxidation

Injection related anxiety in insulin-treated diabetes

Suchergebnisse filtern